Argyle Capital Management Inc. has filed its 13F form on April 29, 2024 for Q1 2024 where it was disclosed a total value porftolio of $255 Million distributed in 118 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $13.6M, Eli Lilly & CO with a value of $10.9M, Merck & Co., Inc. with a value of $7.97M, Mckesson Corp with a value of $7.45M, and Jpmorgan Chase & CO with a value of $6.8M.

Examining the 13F form we can see an increase of $16.1M in the current position value, from $239M to 255M.

Below you can find more details about Argyle Capital Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $255 Million
Healthcare: $57.3 Million
Technology: $40.8 Million
Industrials: $37.8 Million
Financial Services: $31 Million
Energy: $22.5 Million
Consumer Cyclical: $19.5 Million
Consumer Defensive: $13.5 Million
Utilities: $11.2 Million
Other: $21.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History


  • Portfolio
  • No. of Stocks 118
  • Current Value $255 Million
  • Prior Value $239 Million
  • Filing
  • Period Q1 2024
  • Filing Date April 29, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 3 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 64 stocks
Track This Portfolio

Track Argyle Capital Management Inc. Portfolio

Follow Argyle Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.


Stay updated on Argyle Capital Management Inc. with notifications on news.